Supplier Onboarding
Regulatory & Quality Onboarding
Dedicated to ensuring a seamless and efficient onboarding process for all our valued partners. As a trusted pharmaceutical company that emphasizes collaboration, we recognize the importance of establishing strong collaborations with vendors who share our commitment to regulatory compliance and uncompromising quality standards.
The GLN is used to uniquely identify any location or legal entity anywhere in the world. Some companies choose to allocate one GLN for their whole business, while others allocate an individual GLNs for every location they need to identify. This could be a warehouse receiving dock or a hospital bed location in a ward. The GLN supports flexibility for whatever level of location identification is needed. As a GS1 Identification Key, the GLN is unique, thereby allowing trading parties to exchange GLNs for location identification with no danger of number duplication. A GLN can be assigned by a company anywhere in the world and can be used anywhere in the world.
The Regulatory team has established organizational policy to ensure compliance of all Federal and State Agency Licensing Requirements and other applicable Regulatory Authority. The Drug Supply Chain Security Act (DSCSA) requires wholesale distributors and third-party logistics providers to report licensure and other information to annually under sections 503(e)(2) and 584 Federal Food, Drug, and Cosmetic Act.
A2A Alliance Pharmaceuticals supports a range of EDI documents and transmission protocols to transfer information to and from our business partners. In addition, maintains partnerships with various communication and van providers and complies with both the American National Standards Institute (ANSI) and the Healthcare Distribution Alliance (HDA) EDI guidelines. A2A Alliance Pharmaceuticals sends and receives EDI data in real-time, starting at 5:30 a.m. EST and ending at 10:30 p.m. EST, seven days a week.
A2A Alliance Pharmaceuticals supports and operates a group email for each directorate and respective operational area of business. Each directorate's department-wide email is monitored daily to ensure the appropriate information is directed to the appropriate person(s) of responsibility. A2A Alliance Pharmaceuticals ensures an active engagement of communication and strives to be as accessible as possible to achieve operational efficiency. Please allow our personnel the appropriate level of time to achieve the respective obligation of communication and transactional dialogue, even if this includes a negative response. A2A as an organization holds a personnel policy that encompasses accountability standards in regards to communications and accessibility.